Processing your payment...
Please do not close your browser.

Vaccine Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL

16 Mar, 2022 | 156 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 14.25% over the forecast period, the market value of Vaccine is expected to reach US$ 154.60 billion in the year 2027.



Vaccine Market Overview



Vaccines are the most effective and cost-effective way to protect billions of people worldwide. Vaccine development has the potential to transform health by removing the burden of life-threatening infectious diseases from the populations of affluent countries. According to the World Health Organization (WHO), immunisation awareness and government initiatives have helped prevent 2-3 million deaths each year. Increased investments, as well as company mergers and partnerships, are boosting global product production and sales.



To meet the adherence and needs of immunisation policies to eradicate endemic diseases, global product supply increased, which is a significant driver of market growth. Government foundations, hospitals, and pharmaceutical companies are emphasising regular immunisation and providing cost-effective immunisation to people all over the world. Government surveillance has increased in all countries to ensure that everyone is vaccinated at a low or no cost. Another major factor driving market growth is the competitive pipeline, which includes products from both emerging and major players. Because the market is heterogeneous and vast, these players are battling for regulatory approvals for their products. Many companies' main challenge is continuous R&D and a focus on launching novel products.



The report aspects discussed the profile of the top manufacturers of the global Vaccine market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Vaccine Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.





Industry News and Updates:



January 25, 2022: Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age-- 

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age. 



September 29, 2021: Mitsubishi Tanabe to bring plant-derived COVID vaccine to Japan-- 

Mitsubishi Tanabe Pharma has decided to launch the world's first plant-based vaccine in Japan, Nikkei has learned, potentially paving the way to stable COVID-19 vaccine supplies for a country that so far has approved only overseas-made doses.



What are the major Applications, Types and Regions for Vaccine Market?



Market is segmented based on the type, applications, companies and regions.



By Type, it is segmented into




  • Varicella Vaccine

  • Influenza Vaccine

  • Polio Vaccine

  • Hepatitis A Vaccine

  • Rabies Vaccine

  • BCG Vaccine

  • Hepatitis B

  • Pertussis, Diphtheria, Tetanus

  • Pneumococcal

  • Others



By Application, it is segmented into




  • For Adult

  • For Child



Vaccine Market Regional Analysis



North America generated USD 29.43 billion in revenue in 2020 and is expected to dominate the global market during the forecast period. The market in North America is expected to grow steadily and to hold the dominant market share due to a variety of factors such as vaccination awareness, the presence of strong manufacturers, and secure government policy regarding health welfare. It also focuses on implementing immunisation across North American countries by enacting appropriate financing policies. The market value of Asia Pacific is expected to skyrocket in the coming years. Asia Pacific countries have varying levels of economic development, which results in a variety of approaches to immunisation. Because of China's and India's growing populations, Japan dominates the Asia Pacific market with the highest market share. This is the primary reason for the increased demand for injections.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Vaccine Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Vaccine Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Vaccine Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 14.25% over the forecast period (2022-2027)



By Type




  • Varicella Vaccine

  • Influenza Vaccine

  • Polio Vaccine

  • Hepatitis A Vaccine

  • Rabies Vaccine

  • BCG Vaccine

  • Hepatitis B

  • Pertussis, Diphtheria, Tetanus

  • Pneumococcal

  • Others



By Application




  • For Adult

  • For Child



By Companies



AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



156



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Vaccine Report




  • Evaluate Vaccine market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Vaccine market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the growth rate of Vaccine Market?



The Vaccine Market is growing at a CAGR of 14.25% over the next 5 years.



Who are the key players in Vaccine Market?



AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties



What are the significant types of Vaccine Market?



Varicella Vaccine, Influenza Vaccine, Polio Vaccine, Hepatitis A Vaccine, Rabies Vaccine, BCG Vaccine, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Others



What are the major end-use applications of Vaccine Market?



For Adult, For Child



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL VACCINE MARKET BY TYPE

    3. GLOBAL VACCINE MARKET BY APPLICTAION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR VACCINE



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. VACCINE GROWTH

      2. APPLICATION OF VACCINE



    4. IMPACT OF COVID 19



  5. GLOBAL VACCINE MARKET, BY TYPE

    1. INTRODUCTION

    2. VARICELLA VACCINE

    3. INFLUENZA VACCINE

    4. POLIO VACCINE

    5. HEPATITIS A VACCINE

    6. RABIES VACCINE

    7. BCG VACCINE

    8. HEPATITIS B

    9. PERTUSSIS, DIPHTHERIA, TETANUS

    10. PNEUMOCOCCAL

    11. OTHERS       



  6. GLOBAL VACCINE MARKET, BY APPLICATION

    1. INTRODUCTION

    2. FOR ADULT

    3. FOR CHILD



  7. GLOBAL VACCINE MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. ASTRAZENECA

      2. BIONTECH

      3. BOEHRINGER-INGELHEIM

      4. CCBIO

      5. CSL

      6. CUREVAC

      7. ELANCO

      8. GSK

      9. HULAN BIO

      10. INDIAN IMMUNOLOGICALS

      11. MERCK

      12. MINHAI BIOTECHNOLOGY

      13. MITSUBISHI TANABE PHARMA

      14. MODERNA THERAPEUTICS

      15. MYLAN

      16. PLUMBLINE LIFE SCIENCES

      17. SANOFI

      18. TRANSLATE BIO

      19. WALVAX BIOTECHNOLOGY

      20. WUHAN INSTITUTE OF BIOLOGICAL PRODUCTS

      21. ZOTIES





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M